BioSpace News Archive

Partnership enables Hibiscus BioTechnology Studio Companies access to Innoforce’s advanced therapies drug development capabilities.

Karyopharm Therapeutics Inc. today announced that results from the Phase 3 SIENDO study will be presented at the European Society of Medical Oncology’s (ESMO) Virtual Plenary taking place on Thursday, March 17, 2022.

Protagonist Therapeutics (Nasdaq: PTGX) (“Protagonist” or “the Company”) announced today earning a $25 million milestone payment from its collaboration with Janssen Biotech, Inc.

Glooko Inc. today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can work together to improve health outcomes.

Aptatek BioSciences, Inc. announced the completion of a $4 million seed funding round led by hard science investment firm IP Group, Inc., Canterbury Scientific Limited, a leading global OEM developer and supplier of In Vitro Diagnostic (IVD) test consumables, and the National PKU Alliance (NPKUA) also participated in the round.

Xeris Biopharma Holdings, Inc. today announced that Gvoke® (glucagon injection) Kit is now available by prescription.

Orthofix Medical Inc today announced the U.S. Food and Drug Administration 510(k) clearance and the first patient cases with the TrueLok ™ EVO Ring Fixation Syst

2seventy bio, Inc announced today that it has agreed to sell approximately 13,934,427 shares of its common stock to a select group of institutional and accredited investors in a private placement.

Applied Therapeutics, Inc. today announced their abstract #OP005 was accepted as an oral platform presentation at the 2022 Annual Clinical Genetics Meeting of the American College of Molecular Genetics and Genomics, March 22 – 26, 2022 in Nashville, Tennessee.

Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today reported its financial results for the fiscal year ended December 31, 2021.